Become a registered Novo Nordisk Developer


People deserve the freedom to decide which solution works best for them. That is why we would like to make it possible for your solution to connect with our smart insulin pens.

Once you register and have signed the agreement for use of the pen specifications, you will get access to the NovoPen® Interoperability Specifications, SDK source code and simulator tool as well as a technical Questions and Answers to guide you in establishing a connection between your app, device or system and NovoPen® 6 & NovoPen Echo® Plus. In addition, you will receive access to a list of common technical questions and answers.



Presentation of solution


Solution description*

Please describe the product that you would like to connect to the Novo Nordisk smart insulin pens, please state purpose of the solution, general specifications etc.


Users in total (numeric) *

Users split by country *

E.g. Denmark 123, Germany 456, Sweden 789


Regulatory Classification

Please select the current or expected regulatory classification(s) of your solution (select one or more).



Institution/Company information


Company name*

Company registration number *

Company description *

Please describe your value proposition, mission statement, target market, what are the current products on the market and in the pipeline offering(s), customer groups, etc.


NB: Company description must not contain sensitive personal information e.g. health information. Novo Nordisk will immediately delete sensitive personal information. 

Company web page link *

Street address 1 *

Street address 2

Postal code *

City *

State region 

Country *



Contact information


First name *

Last name *

Job title *

E-mail address *

Phone number *

Contact person

Novo Nordisk contact person and contact details (only relevant if you have been in contact with Novo Nordisk previously)



Privacy Notice *


Novo Nordisk A/S, CVR no. 24256790, Novo Allé, 2880 Bagsvaerd, Denmark is responsible for processing your personal data as part of the Novo Nordisk Developer Portal (the “Website”). Novo Nordisk will collect and process personal data about you for the legitimate interest of Novo Nordisk to expand external access to develop solutions which can connect with certain of Novo Nordisk’s smart insulin pens, to verify status as eligible developer to receive Novo Nordisk’s smart insulin pen documents and to send the terms of use for signature, if applicable.

As a data subject, you have the right to access your personal data, you may at any time object to the processing, and/or request to have your information corrected. If you have any complaints about Novo Nordisk’s processing of your personal data, you may contact the Danish Data Protection Agency.

Please visit Novo Nordisk’s privacy notice for further information about Novo Nordisk’s collection and processing of your personal data.